Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Goal: Protect patients, satisfy legal and regulatory duties, preserve the company’s long‑term credibility, and manage the short‑term market shock as responsibly as possible. Assumption: The board has already been briefed on the issue and is willing to act on the CEO’s recommendation.Read the full answer
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer